Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: J Psychiatr Res. 2023 Dec 16;170:147–157. doi: 10.1016/j.jpsychires.2023.12.017

Table 1.

Summary of included models grouped by outcome definition.

Author (year) Population (data source,
location)
Treatment Outcome
definition
(timing)
N No. with
outcome/
mean
response
Predictors included in final model Model type,
performance
Insomnia Severity Index
Blom et al. (2021) Adults with insomnia (4 RCTs, Sweden) CBT-I ISI (EOT) 252 Δ ISI = 5.68 Baseline ISI, baseline SRBQ (items 14, 17, 19, 24), factor 3 (blocking thoughts), factor 8 (napping), factor 10 (checking time) Linear regression, R = 0.21
ISI <8 or Δ ISI >7 and ISI <15 (3–10yrs) 199 133/199 (67%) Baseline ISI, Δ ISI, Δ DBAS, Δ SRBQ, Δ SPAQ Logistic regression, Tjur’s R2 = 0.37
ISI <8 or Δ ISI >7 and ISI <15 (3–10yrs) 199 133/199 (67%) Baseline ISI, Δ ISI, baseline DBAS (items 1, 3, 5), Δ DBAS (items 5, 10), baseline SRBQ (items 4, 5, 7, 15), Δ SRBQ (items 7, 15), Δ Factor 4 (blaming poor sleep), Δ Factor 10 (checking time) Logistic regression, Tjur’s R2 = 0.59
Constantino et al. (2007) Adults with insomnia referred for CBT by sleep specialist (Sleep center, USA) CBT-I Δ daytime interference (EOT) 29 Δ DI: 2.88 Group Therapy Session Report (expectancy, affiliation, critical confrontation, expectancy*affiliation, expectancy*critical confrontation, affiliation*critical confrontation) Linear regression, Adjusted R2 = −0.09
Pruiksma et al. (2020) Active-duty military members with insomnia on psychotropic and/or hypnotic medications for at least one month (RCT, USA) CBT-I Δ ISI (EOT) 99 NR Baseline ISI, baseline BDI score, history of head injury, baseline TST Linear regression, R = 0.24
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ ISI–P (EOT) 47 NR Δ DBAS (sleep expectations, insomnia consequences), ABS (time arising from bed, avoidance of napping), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.26
Δ ISI–P (6m) 47 NR Δ DBAS (sleep expectation, insomnia consequences), ABS (time arising from bed, avoidance of napping), Δ HADS (total), TEPCQ, TAPQ-Participant Linear regression, R = 0.19
Δ ISI–C (EOT) 47 NR Δ DBAS (control of sleep, insomnia consequences), ABS (avoidance of napping, arising during night awakenings), Δ HADS (anxiety subscale), TEPCQ, TAPQ-Clinician Linear regression, R = 0.18
Δ ISI–C (6m) 47 NR Δ DBAS (insomnia consequences subscale, sleep habits subscale), ABS (bedtime hour, arising during night awakenings), Δ HADS (depression subscale), TEPCQ, TAPQ-Global Linear regression, R = 0.33
Forsell et al. (2022) Non-depressed adults with insomnia (RCT, Sweden) CBT-I ISI >8 or Δ ISI ≤7 (EOT) 199 66/199 (33%) ISI, MADRS-S, CORE-9, DBAS (items 4, 11, 17, 20, 24, 25, 28, 29), insomnia knowledge, GSE, SRBQ (items 7,9,25,28), SPAQ (items 1,2,3,4 and additional item), PSS-4, WAI score, TCS score, clinician ratings (activity, contact, sleep restriction and stimulus control, attitude towards sleep and CBT-I, homework, sleep medication, affected adherence, affected sleep, motivation) Logistic regression, Accuracy = 0.67
Pittsburgh Sleep Quality Index
Currie et al. (2002) Adults ≤60 years with insomnia secondary to chronic pain, RCT (RCT, Canada) CBT-I PSQI RCI>1.96 (EOT) 51 20/51 (39.2%) Sleep self-efficacy scale Logistic regression, Accuracy = 0.71
Morgan et al. (2003) Adults ≥30 years using hypnotics for at least the previous month and requested a refill (RCT, UK) CBT-I Δ PSQI (3m) 55 Δ PSQI: 2.8 baseline PSQI score, IPQ (cure/control subscale) Linear regression, R = 0.35
Shi et al. (2021) Adults with insomnia age 18–70 (Cohort study, China) TMS Δ PSQI (EOT) 25 Δ PSQI: 3.20 baseline power envelope connectivity, age, sex PLS regression, Cross-validated R2: Alpha band: 0.60
Beta band: 0.80
Gamma band: 0.66
Delta band: 0.46
Theta band: 0.58
Δ PSQI (1m) 25 Δ PSQI: 5.84 baseline power envelope connectivity, age, sex PLS regression, Cross-validated R2: Alpha band: 0.52
Beta band: 0.62
Gamma band: 0.31
Delta band: 0.28
Theta band: 0.55
Sleep Efficiency
Jansson-Frojmark and Linton (2008) Adults 18–65 years with insomnia (RCT, Sweden) CBT-I Δ SE (1 yr) 64 Δ SE: +13% # of CBT sessions, baseline DBAS Linear regression, R = 0.15
Morgan et al. (2003) Adults ≥30 years who had been taking hypnotics for at least the previous month and requested a refill (RCT, UK) CBT-I Δ SE (3m) 54 Δ SE: +11.3% baseline SE, IPQ (cure/control subscale) Linear regression, R = 0.54
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ SEa (EOT) 47 NR Δ DBAS (control of sleep subscale, insomnia consequences subscale), ABS (time of arising from bed, arising during night awakenings), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.28
Δ SEa (6m) 47 NR Δ DBAS (insomnia consequences subscale, sleep habits subscale), ABS (bedtime hour, avoidance of napping), Δ HADS (anxiety subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.31
Δ SEb (EOT) 47 NR Δ DBAS (causal attributions subscale, sleep expectations subscale), ABS (time arising from bed, avoidance of napping), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.18
Δ SEb (6m) 47 NR Δ DBAS (insomnia consequences subscale, sleep habits subscale), ABS (time arising from bed, avoidance of napping), Δ HADS (depression subscale), TEPCQ, TAPQ-Global Linear regression, R = 0.20
Sleep Onset Latency
Currie et al. (2002) Adults ≤60 years with insomnia secondary to chronic pain, RCT (RCT, Canada) CBT-I SOL ≤30 min (EOT) 51 5/51 (29.4%) BDI, smoking status, sleep medications Logistic regression, Accuracy = 0.71
Espie et al. (2001) Adults with insomnia referred to a sleep clinic (Primary care, Scotland) CBT-I Δ SOL ≥50% (12m) 109 45/109 (41.3%) Insomnia severity, DBAS factor II Logistic regression, Sensitivity = 0.56, Specificity = 0.74
SOL ≤30 min (12m) 109 70/109 (64.2%) Insomnia severity, DBAS factor II Logistic regression, Sensitivity = 0.88, Specificity = 0.35
Δ SOL ≥50% and SOL ≤30 min (12m) 109 38/109 (34.9%) DBAS factor II Logistic regression, Sensitivity = 0.91, Specificity = 0.21
Inoue et al. (2015) Adults aged 20–84 with insomnia (RCT, Japan) Eszopiclone SOL ≤30 min (4 wk) 58 35/58 (60.3%) Age, sex, BMI, number of comorbidities, baseline SOL Logistic regression, AUC = 0.73
Morgan et al. (2003) Adults ≥30 years who had been taking hypnotics for at least the previous month and requested a refill (RCT, UK) CBT-I Δ SOL (3m) 56 Δ SOL: 27.7 min baseline SOL Linear regression, R = 0.37
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ SOLa (EOT) 47 NR Δ DBAS (control of sleep subscale, sleep habits subscale), ABS (avoidance of napping, sleep restriction), Δ HADS (total), TEPCQ, TAPQ-Clinician Linear regression, R = 0.21
Δ SOLa (6m) 47 NR Δ DBAS (control of sleep subscale, sleep habits subscale), ABS (time arising from bed, avoidance of napping), Δ HADS (depression subscale), TEPCQ, TAPQ-Clinician Linear regression, R = 0.29
Δ SOLb (EOT) 47 NR Δ DBAS (control of sleep subscale, sleep expectations subscale), ABS (time of arising from bed, sleep restriction), Δ HADS (depression subscale), TEPCQ, TAPQ-Clinician Linear regression, R = 0.23
Δ SOLb (6m) 47 NR Δ DBAS (sleep expectations subscale, insomnia consequences subscale), ABS (bedtime hour, time of arising from bed), Δ HADS (total), TEPCQ, TAPQ-Clinician Linear regression, R = 0.27
Total Sleep Time
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ TSTa (EOT) 47 NR Δ DBAS (control of sleep, insomnia consequences), ABS (time of arising from bed, sleep restriction), Δ HADS (anxiety subscale), TEPCQ, TAPQ-Clinician Linear regression, R = 0.26
Δ TSTa (6m) 47 NR Δ DBAS (insomnia consequences, sleep habits), ABS (bedtime hour, avoidance of napping), Δ HADS (total), TEPCQ, TAPQ-Participant Linear regression, R = 0.26
Δ TSTb (EOT) 47 NR Δ DBAS (causal attributions, sleep expectations), ABS (avoidance of napping, arising during night awakenings), Δ HADS (anxiety), TEPCQ, TAPQ-Clinician Linear regression, R = 0.32
Δ TSTb (6m) 47 NR Δ DBAS (sleep expectations, sleep habits), ABS (time of arising from bed, arising during night awakenings), Δ HADS (total), TEPCQ, TAPQ-Clinician Linear regression, R = 0.32
Wake After Sleep Onset
Currie et al. (2002) Adults ≤60 years with insomnia secondary to chronic pain, RCT (RCT, Canada) CBT-I WASO ≤30 min (EOT) 51 23/51 (45.1%) Pain severity, smoking status Logistic regression, Accuracy = 0.63
Espie et al. (2001) Adults with insomnia referred to a sleep clinic (Primary care, Scotland) CBT-I Δ WASO ≥50% (12m) 109 54/109 (49.5%) BDI score, SDQ factor IV, insomnia severity Logistic regression, Sensitivity = 0.70, Specificity = 0.64
WASO ≤30 min (12m) 109 69/109 (63.3%) Insomnia severity, STAI state Logistic regression, Sensitivity = 0.77, Specificity = 0.46
Δ WASO ≥50% and WASO ≤30 min (12m) 109 44/109 (40.4%) BDI score, SDQ factor IV Logistic regression, Sensitivity = 0.87, Specificity = 0.42
Inoue et al. (2015) Adults aged 20–84 with insomnia, 46 sleep clinics in (RCT, Japan) Eszopiclone WASO ≤30 min (4 wk) 51 35/51 (68.6%) Age, sex, BMI, number of comorbidities, baseline WASO Logistic regression, AUC = 0.87
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ WASOa (EOT) 47 NR Δ DBAS (sleep expectations, insomnia consequences), ABS (time of arising from bed, arising during night awakenings), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.38
Δ WASOa (6m) 47 NR Δ DBAS (insomnia consequences, sleep habits), ABS (time of arising from bed, arising during night awakenings), Δ HADS (anxiety), TEPCQ, TAPQ-Clinician Linear regression, R = 0.43
Δ WASOb (EOT) 47 NR Δ DBAS (causal attributions, insomnia consequences), ABS (avoidance of napping, sleep restriction), Δ HADS (total), TEPCQ, TAPQ-Clinician Linear regression, R = 0.29
Δ WASOb (6m) 47 NR Δ DBAS (sleep habits, sleep expectations), ABS (bedtime hour, time of arising from bed), Δ HADS (anxiety), TEPCQ, TAPQ-Global Linear regression, R = 0.22
Total Wake Time
Tremblay et al. (2009) Adult women with chronic insomnia secondary to breast cancer (RCT, Canada) CBT-I Δ TWTa (EOT) 47 NR Δ DBAS (control of sleep, insomnia consequences), ABS (time of arising from bed, arising during night awakenings), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.28
Δ TWTa (6m) 47 NR Δ DBAS (control of sleep, insomnia consequences), ABS (time of arising from bed, avoidance of napping), Δ HADS (anxiety subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.30
Δ TWTb (EOT) 47 NR Δ DBAS (causal attributions, insomnia consequences), ABS (avoidance of napping, time of arising from bed), Δ HADS (depression subscale), TEPCQ, TAPQ-Participant Linear regression, R = 0.32
Δ TWTb (6m) 47 NR Δ DBAS (insomnia consequences, sleep habits), ABS (time of arising from bed, avoidance of napping), Δ HADS (depression subscale), TEPCQ, TAPQ-Global Linear regression, R = 0.23
Constantino et al. (2007) Adults with insomnia referred for CBT by sleep specialist (Sleep center, USA) CBT-I Δ TWT (EOT) 49 Δ TWT: 28.47% Group Therapy Session Report (expectancy, affiliation, critical confrontation, expectancy*affiliation, expectancy*critical confrontation, affiliation*critical confrontation) Linear regression, Adjusted R2 = 0.06
Sleep Quality
Jansson-Frojmark and Linton (2008) Adults age 18–65 with insomnia (RCT, Sweden) CBT-I Δ SQ (1 yr) 64 Δ SQ: 1.3 Age Δ DBAS (total), insomnia duration Linear regression, R = 0.09
Linear regression, R = 0.31
Number of Nocturnal Awakenings
Espie et al. (2001) Adults with insomnia referred to a sleep clinic (Primary care, Scotland) CBT-I Δ nWAKE ≥50% (1yr) 109 31/109 (28.4%) BDI Logistic regression, Sensitivity = 0.13, Specificity = 1.0
Enjoyment of Sleep
Espie et al. (2001) Adults with insomnia referred to a sleep clinic (Primary care, Scotland) CBT-I Δ Enjoy ≥50% (1yr) 109 29/109 (26.6%) PSWQ, marital status, credibility Logistic regression, Sensitivity = 0.17, Specificity = 0.94
Outcome: hypnotic-free nights/week
Morgan et al. (2003) Adults ≥30 years who had been taking hypnotics for at least the previous month and requested a refill (RCT, UK) CBT-I Δ hypnotic-free nights/week (3m) 57 Δ hypnotic-free nights/week: −2.2 HADS (anxiety), baseline # hypnotic-free nights/week Linear regression, R = 0.22

Abbreviations: CBT-I = cognitive behavioral therapy for insomnia, ISI = insomnia severity index, PSQI = Pittsburgh Sleep Quality Index, WASO = wake after sleep onset, SOL = sleep onset latency, SE = sleep efficiency, TST = total sleep time, SQ = sleep quality, TWT = total wake time, RCI = reliable change index, PLS = partial least squares, NR = not reported, Δ = change, EOT = end of treatment, m = months, yr = years, wk = weeks, nWAKE = number of nocturnal awakenings, enjoy = enjoyment of sleep, DBAS = Dysfunctional Beliefs About Sleep questionnaire, HADS = Hospital Anxiety and Depression Scale, TEPCQ = Treatment Expectancies and Perceived Credibility Questionnaire, TAPQ = Therapeutic Alliance Perception Questionnaire, ABS = Adherence to Behavioral Strategies, SDQ = Sleep Disorders Questionnaire, BDI = Beck Depression Inventory, SPAQ = Sleep Practices and Attitudes Questionnaire, SRBQ = Sleep Related Behaviors Questionnaire, BMI = body mass index, DI = daytime interference, IPQ = Illness Perception Questionnaire.

a

from sleep diary

b

from polysomnogram.